Induction of human papillomavirus-specific CD4(+) and CD8(+) lymphocytes by E7-pulsed autologous dendritic cells in patients with human papillomavirus type 16- and 18-positive cervical cancer
about
Immunotherapy for human papillomavirus-associated disease and cervical cancer: review of clinical and translational researchCervical cancer isolate PT3, super-permissive for adeno-associated virus replication, over-expresses DNA polymerase delta, PCNA, RFC and RPA.In vitro activity of pertuzumab in combination with trastuzumab in uterine serous papillary adenocarcinoma.Efficient Ex vivo stimulation of Mycobacterium tuberculosis-specific T cells by genetically detoxified Bordetella pertussis adenylate cyclase antigen toxoidsInterleukin-10 increases Th1 cytokine production and cytotoxic potential in human papillomavirus-specific CD8(+) cytotoxic T lymphocytes.hI-con1, a factor VII-IgGFc chimeric protein targeting tissue factor for immunotherapy of uterine serous papillary carcinoma.Enhanced stimulation of anti-ovarian cancer CD8(+) T cells by dendritic cells loaded with nanoparticle encapsulated tumor antigen.Novel antigens in non-small cell lung cancer: SP17, AKAP4, and PTTG1 are potential immunotherapeutic targets.Cancer immunotherapy using RNA-loaded dendritic cells.An effective cancer vaccine modality: lentiviral modification of dendritic cells expressing multiple cancer-specific antigensPolymerase ε (POLE) ultra-mutated tumors induce robust tumor-specific CD4+ T cell responses in endometrial cancer patients.Progress on new vaccine strategies against chronic viral infectionsHuman papillomavirus type 16 E5 protein as a therapeutic target.Human papillomavirus type 16 and 18 E7-pulsed dendritic cell vaccination of stage IB or IIA cervical cancer patients: a phase I escalating-dose trial.Tissue factor expression in ovarian cancer: implications for immunotherapy with hI-con1, a factor VII-IgGF(c) chimeric protein targeting tissue factor.New Approaches to Immunotherapy for HPV Associated Cancers.Induction of tumour-specific CD8(+) cytotoxic T lymphocytes by tumour lysate-pulsed autologous dendritic cells in patients with uterine serous papillary cancerMolecular characterization of antigen-peptide pulsed dendritic cells: immature dendritic cells develop a distinct molecular profile when pulsed with antigen peptideInflammatory Infiltrates in Parathyroid Tumors.Increase of human papillomavirus-16 E7-specific T helper type 1 response in peripheral blood of cervical cancer patients after radiotherapy.Cancer testis antigen Sperm Protein 17 as a new target for triple negative breast cancer immunotherapy.The cancer-testis antigen, sperm protein 17, a new biomarker and immunological target in head and neck squamous cell carcinoma.CpG-ODN-stimulated dendritic cells act as a potent adjuvant for E7 protein delivery to induce antigen-specific antitumour immunity in a HPV 16 E7-associated animal tumour model.Definition of the HLA-A2 restricted peptides recognized by human CD8+ effector T cells by flow-assisted sorting of the CD8+ CD45RA+ CD28- T cell subpopulation.
P2860
Q26744094-D14305E9-772C-48E4-BCCE-8D6323AC4A59Q33434176-45B17AF2-2B14-4F3B-8025-5A20CDC812A3Q33620124-2D0373F4-AD89-4093-97F3-37AC02B3BF4AQ33769116-CEF5F8E8-9394-4C18-9029-C61B7D97EF32Q33804742-D1A138AD-E515-489F-88B3-A7DCAEC27E65Q34253625-844DF4C2-7B5F-45D7-81DC-9D85D811F377Q34860928-D6074DB6-0774-4DF0-8DE6-98D9C026C0EDQ35550108-9A3CEE5C-31AA-44B9-86BE-F4D51821E51CQ35591078-914D2C39-F324-4428-BE4F-8211310A426CQ35747229-5FB74892-38C7-488F-A2FD-EE158C0A439AQ35748591-D05AB3EB-CD05-44A7-AEE0-F7FA11BE0186Q35864857-D48B3CAF-7E0D-4906-BD8A-A872EEC4A521Q36406751-6A260475-104B-41FA-B4F3-33815696EAECQ36483341-9F4C0EEC-77B9-438F-9CCA-A0CE703DCE77Q36972097-2D9A5190-8BCD-4E87-A6B2-2861DF871B2BQ37137430-221017DB-FD8F-48EE-8DD6-B76E53EC8E09Q37352655-EF862AF5-4592-4161-93BB-BF806B793DE0Q37520734-1562C801-37D1-4FC6-BFA7-EDCB9CA8A73EQ38372011-2C53C221-B527-4A57-87D9-089213D89F45Q44280889-8F8B53CD-BF95-485E-8DE2-4B5BDCB0E6F7Q46388405-FB1F5423-A6D2-4916-ADFA-82F7AD470855Q47289028-BC1A49C0-133A-481D-B94F-08DAC77BE937Q47736286-3B655AD0-EACF-420A-98BD-6B504A0AAA47Q52008519-79AE8A35-18B0-4C01-82B7-97B3AF82E509
P2860
Induction of human papillomavirus-specific CD4(+) and CD8(+) lymphocytes by E7-pulsed autologous dendritic cells in patients with human papillomavirus type 16- and 18-positive cervical cancer
description
1999 nî lūn-bûn
@nan
1999 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Induction of human papillomavi ...... nd 18-positive cervical cancer
@ast
Induction of human papillomavi ...... nd 18-positive cervical cancer
@en
type
label
Induction of human papillomavi ...... nd 18-positive cervical cancer
@ast
Induction of human papillomavi ...... nd 18-positive cervical cancer
@en
prefLabel
Induction of human papillomavi ...... nd 18-positive cervical cancer
@ast
Induction of human papillomavi ...... nd 18-positive cervical cancer
@en
P2093
P2860
P1433
P1476
Induction of human papillomavi ...... nd 18-positive cervical cancer
@en
P2093
A D Santin
G P Parham
M Chiriva-Internati
M J Cannon
P L Hermonat
S Pecorelli
P2860
P304
P577
1999-07-01T00:00:00Z